Aggravation by prostaglandin E2 of interleukin‐6‐dependent insulin resistance in hepatocytes
Janin Henkel, Frank Neuschäfer‐Rube, Andrea Pathe‐Neuschäfer‐Rube, Gerhard P. Püschel – 27 August 2009 – Hepatic insulin resistance is a major contributor to fasting hyperglycemia in patients with metabolic syndrome and type 2 diabetes. Circumstantial evidence suggests that cyclooxygenase products in addition to cytokines might contribute to insulin resistance. However, direct evidence for a role of prostaglandins in the development of hepatic insulin resistance is lacking.